The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis
Dennis Kobelt(Max Delbrück Center), Ulrike Stein(Max Delbrück Center)
Cited by 14
Related Papers
Novel Effect of Antihelminthic Niclosamide on S100A4-Mediated Metastatic Progression in Colon Cancer
|JNCI Journal of the National Cancer Institute|2011|211
Epigenetic silencing of miR-520c leads to induced S100A4 expression and its mediated colorectal cancer progression
|Oncotarget|2017|55
The importance of developing therapies targeting the biological spectrum of metastatic disease
|Clinical & Experimental Metastasis|2019|13